A compilation of fatal and control concentrations of drugs in postmortem femoral blood

Journal of Forensic Sciences

Volumn 42, Issue 1, 1997, Pages 79-87

  Druid, Henrik ^a   Holmgren, Per ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

drug concentrations; fatality; femoral blood; forensic science; forensic toxicology; postmortem

Indexed keywords

ALIMEMAZINE; ALPRAZOLAM; AMITRIPTYLINE; BIPERIDEN; CAFFEINE; CARBAMAZEPINE; CARISOPRODOL; CHLOROQUINE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; CODEINE; DESIPRAMINE; DIAZEPAM; DILTIAZEM; DRUG; EPHEDRINE; FLUNITRAZEPAM; FLUVOXAMINE; IMIPRAMINE; KETAMINE; LIDOCAINE; MAPROTILINE; MELPERONE; MEPIVACAINE; METHADONE; MIANSERIN; PARACETAMOL; UNINDEXED DRUG;

ARTICLE; AUTOPSY; CAUSE OF DEATH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTOXICATION; FATALITY; FEMORAL ARTERY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0031012173     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs14071j     Document Type: Article

References (33)

1. Stead AH, Moffat AC. A collection of therapeutic, toxic, and fatal blood drug concentrations in man. Hum Toxicol 1983;3:437-64.
2. Baselt RC, Cravey RH. A compendium of therapeutic and toxic concentrations of toxicologically significant drugs in human bioflu ids. J Anal Toxicol 1977;1:81-103.
3. Clarke's isolation and identification of drugs. Second edition. Moffat, AC, editor. The Pharmaceutical press, London 1986.
4. Meyer FP. Indicative therapeutic and toxic drug concentrations in plasma: A tabulation. Int J Clin Pharmacol Ther 1994;32:71-81.
5. Winek CL. Drug and chemical blood-level data 1994. Pittsburgh PA.
6. Schulz M, Schmoldt, A. Zusammenstellung therapeutischer an toxischer Plasmakonzentrationsbereiche von Arzneistoffen. Anaesthesist 1994;43:835-44.
7. Prouty RW, Andersen WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 1990;35:243-70.
8. Vorpahl TE, Coe JI. Correlation of antemortem and postmortem digoxin levels. J Forensic Sci 1978;23:329-34.
9. Gomez HF, McKinney P, Phillips S, Roberts DV, Brent J, Watsson WA. Postmortem acetaminophen pharmacokinetics: An experimental study of site and time-dependent concentration changes. J Forensic Sci 1995;40:980-2.
10. Robertson MD, Drummer OH. Postmortem drug metabolism by bacteria. J Forensic Sci 1995;40:382-6.
11. Quatrehomme G, Bourret F, Liao BS, Oilier A. An experimental methodology for the study of postmortem changes in toxic concentrations of drugs, using secobarbital as an example. J Forensic Sci 1994;39:1300-4.
12. Hilberg T, Bugge A, Beylich KM, Ingum J, Bjorneboe A, Morland J. An animal model of postmortem amitriptyline redistribution. J Forensic Sci 1992;38:81-90.
13. Hilberg T, Mörland J, Björnboe A. Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 1994;64:47-55.
14. Hearn WL, Keran EE, Wei H, Hime G. Site-dependent postmortem changes in blood cocaine concentrations. J Forensic Sci 1991; 36:673-84.
15. Pounder DJ, Owen V, Quigley C. Postmortem changes in blood amitriptyline concentration. Am J Forensic Med Pathol 1994; 15:224-30.
16. Yonemitsu K, Pounder DJ. Postmortem changes in blood tranylcypromine concentration: Competing redistribution and degradation effects. Forensic Sci Int 1993;59:177-84.
17. Isenschmidt DS, Levine BS, Caplan YH. A comprehensive study of the stability of cocaine and its metabolites. J Anal Toxicol 1989;13:250-6.
18. Pounder DJ, Jones GR. Post mortem drug redistribution - a toxico-logical nightmare. Forensic Sci Int 1990;45:253-63.
19. Yonemitsu K, Pounder DJ. Postmortem toxico-kinetics of co-proxamol. Int J Leg Med 1992;104:347-53.
20. Hilberg T, Bugge A, Beylich KM, Mörland J, Bjömboe A. Diffusion as a mechanism of postmortem drug redistribution: An experimental study in rats. Int J Leg Med 1992;105:87-91.
21. Pounder DJ, Hartley AK, Watmough PJ. Postmortem redistribution and degradation of dothiepin. Am J Forensic Med Pathol 1994; 15:231-5.
22. Sharp ME. Inconsistencies in recent compilations of therapeutic drug levels. TIAFT Bullentin 1994;25(3):11-3.
23. Jones GR. Compilation of therapeutic drug levels. TIAFT Bulletin 1994;25(4):15-8.
24. Druid H, Holmgren P, Löwenhielm, P. Computer-assisted systems for forensic pathology and forensic toxicology. J Forensic Sci 1996;41(5):830-6.
25. The National Board of Forensic Medicine. Principles and procedures of forensic autopsy - bases for national guidelines. Information 3, 1994. Stockholm.
26. Martin A, Pounder DJ. Postmortem toxico-kinetics of trazodone. Forensic Sci Int 1992;56:201-7.
27. Murphy JM, Motiwala R, Devinsky O. Phenytoin intoxication. South Med J 1991;84:1199-204.
28. Jones GR, Pounder DJ. Site dependence of drug concentrations in postmortem blood - a case study. J Anal Toxicol 1987;11:186-90.
29. Apple, FS. Postmortem tricyclic antidepressant concentrations: Assessing cause of death using parent drug to metabolite ratio. J Anal Toxicol 1989;13:197-8.
30. Bailey DN. Tricyclic antidepressants: Interpretation of blood and tissue levels in fatal overdose. J Anal Toxicol 1979;3:43-6.
31. Hebb JH, Caplan YH, Crooks CR, Mergner WJ. Blood and tissue concentrations of tricyclic antidepressant drugs in postmortem cases: Literature survey and a study of forty cases. J Anal Toxicol 1982;6:209-16.
32. Brosen K, Gram LF. Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 1989; 36:537-49.
33. Dahl ML, Bertilsson L. Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Invited review. Pharmacogenetics 1993;3:61-70.